ClinicalTrials.gov record
Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension
ClinicalTrials.gov ID: NCT00281593
Public ClinicalTrials.gov record NCT00281593. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Double-dummy, Placebo-controlled, 3x4 Factorial Design Trial to Evaluate Telmisartan 20 and 80 mg Tablets in Combination With Ramipril 1.25, 10, and 20 mg Capsules After Eight Weeks of Treatment in Patients With Stage I or II Hypertension, With an ABPM Sub-study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To identify dose combinations of telmisartan and ramipril that are more effective in reducing diastolic blood pressure than each of the respective monotherapies in patients with Stage I or II hypertension.
Study identification
- NCT ID
- NCT00281593
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,354 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2006 (Type not available)
- Primary completion
- Apr 2007 (Actual)
- Completion
- Not listed
- Last update posted
- Dec 28, 2017
Started 2006
United States locations
- U.S. sites
- 70
- U.S. states
- 28
- U.S. cities
- 61
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1236.1.511 Boehringer Ingelheim Investigational Site | Glendale | Arizona | — | — |
| 1236.1.574 Boehringer Ingelheim Investigational Site | Tempe | Arizona | — | — |
| 1236.1.501 Boehringer Ingelheim Investigational Site | Tucson | Arizona | — | — |
| 1236.1.557 Boehringer Ingelheim Investigational Site | Tucson | Arizona | — | — |
| 1236.1.523 Boehringer Ingelheim Investigational Site | Buena Park | California | — | — |
| 1236.1.514 Boehringer Ingelheim Investigational Site | Concord | California | — | — |
| 1236.1.560 Boehringer Ingelheim Investigational Site | Encinitas | California | — | — |
| 1236.1.573 Boehringer Ingelheim Investigational Site | Long Beach | California | — | — |
| 1236.1.516 Boehringer Ingelheim Investigational Site | Los Angeles | California | — | — |
| 1236.1.529 Boehringer Ingelheim Investigational Site | Roseville | California | — | — |
| 1236.1.519 Boehringer Ingelheim Investigational Site | Tustin | California | — | — |
| 1236.1.543 Boehringer Ingelheim Investigational Site | Westlake Village | California | — | — |
| 1236.1.528 Boehringer Ingelheim Investigational Site | Boulder | Colorado | — | — |
| 1236.1.530 Boehringer Ingelheim Investigational Site | Farmington | Connecticut | — | — |
| 1236.1.572 Boehringer Ingelheim Investigational Site | DeLand | Florida | — | — |
| 1236.1.577 Boehringer Ingelheim Investigational Site | Hialeah | Florida | — | — |
| 1236.1.526 Boehringer Ingelheim Investigational Site | Jupiter | Florida | — | — |
| 1236.1.527 Boehringer Ingelheim Investigational Site | Largo | Florida | — | — |
| 1236.1.503 Anchor Research Center | Naples | Florida | — | — |
| 1236.1.520 Boehringer Ingelheim Investigational Site | New Port Richey | Florida | — | — |
| 1236.1.571 Boehringer Ingelheim Investigational Site | Pembroke Pines | Florida | — | — |
| 1236.1.565 Boehringer Ingelheim Investigational Site | Blue Ridge | Georgia | — | — |
| 1236.1.538 Boehringer Ingelheim Investigational Site | Meridian | Idaho | — | — |
| 1236.1.532 Boehringer Ingelheim Investigational Site | Peoria | Illinois | — | — |
| 1236.1.553 Boehringer Ingelheim Investigational Site | Avon | Indiana | — | — |
| 1236.1.546 River Cities Cardiology Research Inst of Middle America | Jeffersonville | Indiana | — | — |
| 1236.1.563 Boehringer Ingelheim Investigational Site | Valparaiso | Indiana | — | — |
| 1236.1.517 Boehringer Ingelheim Investigational Site | Newton | Kansas | — | — |
| 1236.1.531 Boehringer Ingelheim Investigational Site | Wichita | Kansas | — | — |
| 1236.1.566 Boehringer Ingelheim Investigational Site | Richmond | Kentucky | — | — |
| 1236.1.551 Boehringer Ingelheim Investigational Site | Auburn | Maine | — | — |
| 1236.1.536 Boehringer Ingelheim Investigational Site | Haverhill | Massachusetts | — | — |
| 1236.1.576 Boehringer Ingelheim Investigational Site | North Dartmouth | Massachusetts | — | — |
| 1236.1.561 Clinical Research Center of Cape Cod | West Yarmouth | Massachusetts | — | — |
| 1236.1.555 Boehringer Ingelheim Investigational Site | Cadillac | Michigan | — | — |
| 1236.1.509 Boehringer Ingelheim Investigational Site | Troy | Michigan | — | — |
| 1236.1.541 Boehringer Ingelheim Investigational Site | Excelsior Springs | Missouri | — | — |
| 1236.1.556 Boehringer Ingelheim Investigational Site | Las Vegas | Nevada | — | — |
| 1236.1.525 Physicians Research Center, LLC, Toms River | Toms River | New Jersey | — | — |
| 1236.1.508 Boehringer Ingelheim Investigational Site | Albuquerque | New Mexico | — | — |
| 1236.1.522 Boehringer Ingelheim Investigational Site | Albuquerque | New Mexico | — | — |
| 1236.1.542 Boehringer Ingelheim Investigational Site | Albuquerque | New Mexico | — | — |
| 1236.1.547 Boehringer Ingelheim Investigational Site | Cincinnati | Ohio | — | — |
| 1236.1.567 Boehringer Ingelheim Investigational Site | Columbus | Ohio | — | — |
| 1236.1.515 Boehringer Ingelheim Investigational Site | Kettering | Ohio | — | — |
| 1236.1.575 Boehringer Ingelheim Investigational Site | Tulsa | Oklahoma | — | — |
| 1236.1.554 Boehringer Ingelheim Investigational Site | Corvallis | Oregon | — | — |
| 1236.1.524 Boehringer Ingelheim Investigational Site | Eugene | Oregon | — | — |
| 1236.1.544 Boehringer Ingelheim Investigational Site | Medford | Oregon | — | — |
| 1236.1.545 Boehringer Ingelheim Investigational Site | Portland | Oregon | — | — |
| 1236.1.569 Boehringer Ingelheim Investigational Site | Erie | Pennsylvania | — | — |
| 1236.1.505 Ledeeach Family Medicine | Harleysville | Pennsylvania | — | — |
| 1236.1.564 Boehringer Ingelheim Investigational Site | Tipton | Pennsylvania | — | — |
| 1236.1.534 Boehringer Ingelheim Investigational Site | Cumberland | Rhode Island | — | — |
| 1236.1.539 Boehringer Ingelheim Investigational Site | Spartanburg | South Carolina | — | — |
| 1236.1.568 Boehringer Ingelheim Investigational Site | Carrollton | Texas | — | — |
| 1236.1.549 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 1236.1.559 Boehringer Ingelheim Investigational Site | Houston | Texas | — | — |
| 1236.1.548 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 1236.1.550 Boehringer Ingelheim Investigational Site | San Antonio | Texas | — | — |
| 1236.1.570 Boehringer Ingelheim Investigational Site | The Colony | Texas | — | — |
| 1236.1.510 Boehringer Ingelheim Investigational Site | Salt Lake City | Utah | — | — |
| 1236.1.513 Boehringer Ingelheim Investigational Site | Salt Lake City | Utah | — | — |
| 1236.1.521 Boehringer Ingelheim Investigational Site | Salt Lake City | Utah | — | — |
| 1236.1.512 Boehringer Ingelheim Investigational Site | Sandy City | Utah | — | — |
| 1236.1.535 Boehringer Ingelheim Investigational Site | Sandy City | Utah | — | — |
| 1236.1.502 Boehringer Ingelheim Investigational Site | Falls Church | Virginia | — | — |
| 1236.1.504 Boehringer Ingelheim Investigational Site | Madison | Wisconsin | — | — |
| 1236.1.540 Boehringer Ingelheim Investigational Site | Madison | Wisconsin | — | — |
| 1236.1.562 Boehringer Ingelheim Investigational Site | Menomonee Falls | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00281593, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 28, 2017 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00281593 live on ClinicalTrials.gov.